StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Questions for this Presentation

<< Previous

Bullboard Posts

Next >>

Comment by gojotv!on Apr 22, 2021 5:16pm

92 Views

Post# 33052134

RE:RE:RE:RE:RE:Questions for this Presentation

You're a patient man, Jonnyboy.
Our bashers are armchair managers who don't know the first thing about business in genral, let alone this one.
I wouldn't have had the patience. I woulda just said, "Read Dr. Covey" and left to find more money to buy shares..
I'm not above profiting from the ignorance of others... lol.

Jonnyboy85 wrote: He was just talking over most of the ignorant stockhouse bullboard gutter trash heads:) no wonder none of you got it. There are no stupid ideas, only stupid people.

https://hbr.org/2015/08/making-mergers-acquisitions-and-other-business-combinations-work

In casual conversation, the idea of creating value in combinations is often expressed as 1 + 1 = 3, or some such mathematical metaphor.

https://courses.lumenlearning.com/suny-hccc-introbusiness/chapter/mergers-and-acquisitions/

When businesses acquire other businesses or operations that were previously competitors, suppliers, buyers, or sellers, they are engaging in a strategy known as integration. This strategy is based on the possibility of synergy, the idea that the sum of two entities will be greater than their individual parts—often expressed as 1+1=3.

https://onlinelibrary.wiley.com/doi/pdf/10.1002/9781119207191.oth2

Synergy This is the 1 + 1 = 3 effect where the impact of two companies combining creates a stronger company than the sum of the two companies when they were independent of each other. Expense synergies (including headcount reductions) refer to the situation following a merger or acquisition where functions that were duplicated across the two companies can now be reduced when they are combined (e.g. there ’ s only need for one CEO, not two).

molotov420 wrote: Thank god he didnt say 1+1=3 lol. Someone must have told him to cut that dumb shyt out.

One thing to note is he seemed to hint that Covid revs are unpredictable now...maybe we dont see such high amounts in one of the upcoming quarters.